The AHA today submitted comments to the Centers for Medicare & Medicaid Services on an advanced notice of proposed rulemaking on potential options to strengthen the supply chain for American-made personal protective equipment and essential medicines. The AHA agreed with CMS’ approach to provide incentives to hospitals and health systems to purchase domestically made products and said that such incentives should be accessible to as many hospitals as possible, recognize the cost differential for domestically manufactured goods and be implemented without excessive administrative burden. The AHA made additional recommendations to CMS, including making a public designation voluntary based on domestic procurement percentages, implementing separate Medicare payments in a non-budget-neutral manner, and deprioritizing the development of a structural measure in the inpatient quality reporting program. 

Headline
The Health Sector Coordinating Council’s Cybersecurity Working Group has released a guide on third-party artificial intelligence risk and AI supply…
Headline
The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients. The order imposes a…
Headline
The Administration for Strategic Preparedness and Response March 24 announced an investment to expand the domestic manufacturing of propofol and metoprolol.…
Headline
The Administration for Strategic Preparedness and Response announced March 5 that it will invest in the domestic production of thebaine, an ingredient…
Headline
The Supreme Court Feb. 20 ruled that the International Emergency Economic Powers Act does not authorize the imposition of global tariffs. The court held that…
Headline
The Centers for Medicare & Medicaid Services Jan. 26 released an advanced notice of proposed rulemaking seeking comments on potential future policies to…